Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-19T21:01:07.368Z Has data issue: false hasContentIssue false
  • English
  • Français

In pursuit of the holy grail: Improving C. difficile testing appropriateness with iterative electronic health record clinical decision support and targeted test restriction

Published online by Cambridge University Press:  04 June 2021

Norah S. Karlovich ,
Suchita Shah Sata ,
Brian Griffith ,
Ashley Coop ,
Ibukunoluwa C. Kalu ,
John J. Engemann ,
Jessica Seidelman ,
Nicholas A. Turner ,
Christopher R. Polage  and
Becky A. Smith
...Show all authors
Norah S. Karlovich
Affiliation:
School of Medicine, Duke University, Durham, North Carolina
Suchita Shah Sata
Affiliation:
Division of General Internal Medicine, Department of Medicine, Duke University, Durham, North Carolina
Brian Griffith
Affiliation:
Division of General Internal Medicine, Department of Medicine, Duke University, Durham, North Carolina
Ashley Coop
Affiliation:
Duke Health Performance Services, Durham, North Carolina
Ibukunoluwa C. Kalu
Affiliation:
Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University, Durham, North Carolina
John J. Engemann
Affiliation:
Raleigh Infectious Diseases, RaleighNorth Carolina
Jessica Seidelman
Affiliation:
Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina
Nicholas A. Turner
Affiliation:
Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina
Christopher R. Polage
Affiliation:
Department of Pathology, Duke University, Durham, North Carolina
Becky A. Smith
Affiliation:
Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina
Sarah S. Lewis*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina
*
Author for correspondence: Sarah S. Lewis, E-mail: Sarah.stamps@duke.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine the impact of electronic health record (EHR)–based interventions and test restriction on Clostridioides difficile tests (CDTs) and hospital-onset C. difficile infection (HO-CDI).

Design:

Quasi-experimental study in 3 hospitals.

Setting:

957-bed academic (hospital A), 354-bed (hospital B), and 175-bed (hospital C) academic-affiliated community hospitals.

Interventions:

Three EHR-based interventions were sequentially implemented: (1) alert when ordering a CDT if laxatives administered within 24 hours (January 2018); (2) cancellation of CDT orders after 24 hours (October 2018); (3) contextual rule-driven order questions requiring justification when laxative administered or lack of EHR documentation of diarrhea (July 2019). In February 2019, hospital C implemented a gatekeeper intervention requiring approval for all CDTs after hospital day 3. The impact of the interventions on C. difficile testing and HO-CDI rates was estimated using an interrupted time-series analysis.

Results:

C. difficile testing was already declining in the preintervention period (annual change in incidence rate [IR], 0.79; 95% CI, 0.72–0.87) and did not decrease further with the EHR interventions. The laxative alert was temporally associated with a trend reduction in HO-CDI (annual change in IR from baseline, 0.85; 95% CI, 0.75–0.96) at hospitals A and B. The gatekeeper intervention at hospital C was associated with level (IRR, 0.50; 95% CI, 0.42-0.60) and trend reductions in C. difficile testing (annual change in IR, 0.91; 95% CI, 0.85–0.98) and level (IRR 0.42; 95% CI, 0.22–0.81) and trend reductions in HO-CDI (annual change in IR, 0.68; 95% CI, 0.50–0.92) relative to the baseline period.

Conclusions:

Test restriction was more effective than EHR-based clinical decision support to reduce C. difficile testing in our 3-hospital system.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 43 , Issue 7 , July 2022 , pp. 840 - 847
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

a

Authors of equal contribution.

References

Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of healthcare-associated infections. N Engl J Med 2014;370:1198–1208.CrossRefGoogle Scholar
Zimlichman, E, Henderson, D, Tamir, O, et al. Healthcare-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013;173:2039–2046.CrossRefGoogle ScholarPubMed
Guh, AY, Mu, Y, Winston, LG, et al. Trends in US burden of Clostridioides difficile infection and outcomes. N Engl J Med 2020;382:1320–1330.CrossRefGoogle Scholar
Moehring, RW, Lofgren, ET, Anderson, DJ. Impact of change to molecular testing for Clostridium difficile infection on healthcare-facility–associated incidence rates. Infect Control Hosp Epidemiol 2013;34:1055–1061.CrossRefGoogle ScholarPubMed
Polage, CR, Gyorke, CE, Kennedy, MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 2015;175:1792–1801.CrossRefGoogle ScholarPubMed
Hospital value-based purchasing. Centers for Medicare & Medicaid Services website. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/Hospital-Value-Based-Purchasing-. Accessed January 13, 2021.Google Scholar
McDonald, LC, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66(7):e1–e48.CrossRefGoogle Scholar
Cook, PP, Nichols, S, Coogan, M, Opera, J, DeHart, M. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections. Am J Infect Control 2020;48:1019–1022.CrossRefGoogle ScholarPubMed
Fleming, MS, Hess, O, Albert, HL, et al. Test stewardship, frequency and fidelity: impact on reported hospital-onset Clostridioides difficile . Infect Control Hosp Epidemiol 2019;40:710–712.CrossRefGoogle ScholarPubMed
Friedland, AE, Brown, S, Glick, DR, Lusby, MC, Lemkin, D, Leekha, S. Use of computerized clinical decision support for diagnostic stewardship in Clostridioides difficile testing: an academic hospital quasi-experimental study. J Gen Intern Med 2019;34:31–32.CrossRefGoogle ScholarPubMed
Khoury, JA, Sistrunk, WW, Hixson, F, et al. Sustained reduction in rates of hospital-onset Clostridium difficile infection using an automated electronic health record protocol. Am J Infect Control 2018;46:542–548.CrossRefGoogle ScholarPubMed
Madden, GR, German Mesner, I, Cox, HL, et al. Reduced Clostridium difficile tests and laboratory-identified events with a computerized clinical decision support tool and financial incentive. Infect Control Hosp Epidemiol 2018;39:737–740.CrossRefGoogle ScholarPubMed
Sperling, K, Priddy, A, Suntharam, N, Feuerhake, T. Optimizing testing for Clostridium difficile infection: a quality improvement project. Am J Infect Control 2019;47:340–342.CrossRefGoogle ScholarPubMed
White, DR, Hamilton, KW, Pegues, DA, Hanish, A, Umscheid, CA. The impact of a computerized clinical decision support tool on inappropriate Clostridium difficile testing. Infect Control Hosp Epidemiol 2017;38:1204–1208.CrossRefGoogle ScholarPubMed
Kara, A, Tahir, M, Snyderman, W, Brinkman, A, Fadel, W, Dbeibo, L. Why do clinicians order inappropriate Clostridium difficile testing? An exploratory study. Am J Infect Control 2019;47:285–289.CrossRefGoogle ScholarPubMed
Kinlay, J, Sandora, TJ. A qualitative study to identify reasons for Clostridium difficile testing in pediatric inpatients receiving laxatives or stool softeners. Am J Infect Control 2017;45:539–541.CrossRefGoogle ScholarPubMed
Mizusawa, M, Small, BA, Hsu, YJ, et al. Prescriber behavior in Clostridioides difficile testing: a 3-hospital diagnostic stewardship intervention. Clin Infect Dis 2019;69:2019–2021.CrossRefGoogle ScholarPubMed
Quan, KA, Yim, J, Merrill, D, et al. Reductions in Clostridium difficile infection (CDI) rates using real-time automated clinical criteria verification to enforce appropriate testing. Infect Control Hosp Epidemiol 2018;39:625–627.CrossRefGoogle ScholarPubMed
Rock, C, Mizusawa, M, Small, B, et al. Implementation of electronic medical record hard stop alerts for inappropriate Clostridium difficile tests in academic and community hospital setting; impact on testing rates and clinical outcomes. Open Forum Infect Dis 2017;4 suppl 1:S608.CrossRefGoogle Scholar